Investigations on the antilipolytic activity of sulfonylureas in man with indications on limit dosages concerning their insulin-secreting properties.
D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D004305:Dose-Response Relationship, Drug; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005905:Glyburide / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D008053:Lipid Mobilization / Q000187:drug effects*; D008297:Male; D013997:Time Factors; D014044:Tolbutamide / Q000008:administration & dosage* / Q000494:pharmacology*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014044:Tolbutamide; D005905:Glyburide